Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30019485HIVENSG00000126067.12protein_codingPSMB2YesNo5690A0A087WVV1
B7Z478
P49721
TVIS30023171HIVENSG00000126067.12protein_codingPSMB2YesNo5690A0A087WVV1
B7Z478
P49721
TVIS20033288HPVENSG00000126067.12protein_codingPSMB2YesNo5690A0A087WVV1
B7Z478
P49721
TVIS20048030HPVENSG00000126067.12protein_codingPSMB2YesNo5690A0A087WVV1
B7Z478
P49721
TVIS44043525HTLV-1ENSG00000126067.12protein_codingPSMB2YesNo5690A0A087WVV1
B7Z478
P49721
TCGA Plot Options
Drug Information
GenePSMB2
DrugBank IDDB08889
Drug NameCarfilzomib
Target IDBE0002349
UniProt IDP49721
Regulation Typeinhibitor
PubMed IDs17591945
CitationsKuhn DJ, Chen Q, Voorhees PM, Strader JS, Shenk KD, Sun CM, Demo SD, Bennett MK, van Leeuwen FW, Chanan-Khan AA, Orlowski RZ: Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood. 2007 Nov 1;110(9):3281-90. Epub 2007 Jun 25.
GroupsApproved; Investigational
Direct ClassificationOligopeptides
SMILESCC(C)C[C@H](NC(=O)[C@H](CCC1=CC=CC=C1)NC(=O)CN1CCOCC1)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]1(C)CO1
Pathways
PharmGKBPA166165203
ChEMBLCHEMBL451887